Skip to content
healthcare.dev

Jadenu

NDC 0078-0727, deferasirox, granule, from Novartis Pharmaceuticals Corporation.

Product NDC
0078-0727
Status
Listed
Labeler
Novartis Pharmaceuticals Corporation
Dosage form
GRANULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA207968
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0727 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DEFERASIROX90 mg/1

Pharmacologic classes

Cytochrome P450 1A2 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Iron Chelating Activity [MoA]; Iron Chelator [EPC]

Package NDCNDC-11Package
0078-0727-150007807271530 PACKET in 1 CARTON (0078-0727-15) / 1 GRANULE in 1 PACKET (0078-0727-19)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/fee89140-fff1-4443-9f42-24ac004fcda1

Use it

Look up 0078-0727 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0727 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0078-0727. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.